Position in ATOS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$178,297
-$332,243 QoQ
Shares Held
92,382
-4.8% QoQ
Ownership
0.926%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 31 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. ATOS ranks #410 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ATOS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $178,297 | 92,382 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $510,540 | 97,061 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $809,426 | 1,371,909 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,185,184 | 1,362,282 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,079,314 | 1,300,379 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,906,680 | 2,845,792 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,645,325 | 2,814,177 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $4,277,957 | 2,814,446 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,295,923 | 2,769,684 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,182,181 | 1,212,323 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $981,133 | 1,114,924 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $815,906 | 1,102,576 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,401,891 | 1,112,612 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $871,837 | 1,210,885 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $646,412 | 1,219,647 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,014,621 | 1,222,436 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,330,418 | 1,220,567 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,566,468 | 2,053,175 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,207,649 | 2,004,781 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $6,875,861 | 2,109,160 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $12,442,468 | 1,968,745 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,029,920 | 488,114 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $85,407 | 89,903 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $217,565 | 89,903 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $341,631 | 89,903 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $119,570 | 89,903 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||